(Q34523194)

2 August 2017

1 reference

title

Safety of inhaled corticosteroids in children (English)

1 reference

2 August 2017

David B Allen

1

1 reference

2 August 2017

1 March 2002

1 reference

2 August 2017

Pediatric Pulmonology

1 reference

2 August 2017

33

1 reference

2 August 2017

3

1 reference

2 August 2017

208-220

1 reference

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

2 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

A comparison of the efficacy and safety of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Inhaled and nasal corticosteroids: factors affecting the risks of systemic adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Inhaled and nasal corticosteroids: safety aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Clinical use of inhaled corticosteroids in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Improvement of pressurised aerosol deposition with Nebuhaler spacer device

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Integrated plasma cortisol concentration in children with asthma receiving long‐term inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Growth suppression by glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Long-term effects of budesonide or nedocromil in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Effect of long-term treatment with inhaled budesonide on adult height in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Glucocorticoids and growth in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucocorticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Periodical changes of short term growth velocity ('mini growth spurts') in human growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Knemometry in assessment of linear growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Growth and childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Attained adult height after childhood asthma: effect of glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Does treatment of asthmatic children with inhaled corticosteroids affect their adult height?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Duration of growth suppressive effects of regular inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Corticosteroid-induced bone loss. Prevention and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Pharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Adrenal function in children with bronchial asthma treated with beclomethasone dipropionate or budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Budesonide treatment of moderate and severe asthma in children: a dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Benefits and risks of inhaled glucocorticoids in children with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Therapeutic inhalation agents and devices. Effectiveness in asthma and bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Endocrine and lung function in asthmatic children on inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Adrenocortical suppression following treatment with beclomethasone and budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Limitations of short-term studies in predicting long-term adverse effects of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

The safety of inhaled corticosteroid therapy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Bone loss in response to long-term glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Linear growth of very young asthmatic children treated with high-dose nebulized budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Noncompliance and treatment failure in children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Choosing a long-term controller medication in childhood asthma. The proverbial two-edged sword

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

The effect on growth of childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Anti-inflammatory drugs for controlling asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Randomised placebo-controlled trial of inhaled sodium cromoglycate in 1-4-year-old children with moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Once-daily theophylline reduces serum eosinophil cationic protein and eosinophil levels in induced sputum of asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Anti-IgE antibody therapy for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.10040

21 January 2018

Identifiers

DOI

10.1002/PPUL.10040

1 reference

2 August 2017

1 reference

PubMed ID

11836801